A 4-year-old child with measles develops secondary bacterial pneumonia with productive cough and fever persisting beyond day 5 of rash onset. Chest X-ray shows lobar consolidation. Which antibiotic is the drug of choice for treatment of this complication?

Explanation

## Secondary Bacterial Infection in Measles: Antibiotic Management ### Context: Measles and Secondary Infections **Key Point:** Measles causes immunosuppression and increases susceptibility to secondary bacterial infections, most commonly pneumonia, otitis media, and diarrhea. Bacterial superinfection occurs in 5–15% of measles cases. **High-Yield:** Secondary bacterial pneumonia in measles is typically caused by *Streptococcus pneumoniae* or *Haemophilus influenzae type b* (in unvaccinated children). First-line empiric coverage requires a broad-spectrum agent. ### Choice of Antibiotic: Ceftriaxone **Clinical Pearl:** Ceftriaxone is the drug of choice for community-acquired pneumonia (CAP) in children because it provides excellent coverage against: - *Streptococcus pneumoniae* (including penicillin-resistant strains) - *Haemophilus influenzae* (including ampicillin-resistant strains) - *Moraxella catarrhalis* - Gram-negative organisms ### Dosing in Pediatrics | Condition | Dose | Frequency | Route | |-----------|------|-----------|-------| | CAP (non-severe) | 50–80 mg/kg/day | Once daily or divided | IV/IM | | CAP (severe) | 80 mg/kg/day | Divided doses | IV | | Maximum | 4 g/day | — | — | ### Why Not Other Options? | Agent | Limitation | |-------|----------| | **Fluoroquinolone** | Not first-line in pediatrics; reserved for resistant organisms or special indications; poor bone penetration in children | | **Vancomycin** | Reserved for MRSA or penicillin-allergic patients with severe infection; not empiric choice for CAP in non-MRSA endemic areas | | **Clindamycin** | Good for anaerobes and some gram-positives, but inadequate coverage for *H. influenzae*; not first-line for CAP | **Warning:** Do NOT use amoxicillin or ampicillin empirically — resistance rates of *H. influenzae* and *S. pneumoniae* are high in India (>30% for ampicillin-resistant *H. influenzae*). ### Management Algorithm ```mermaid flowchart TD A[Measles + fever, cough beyond day 5]:::outcome A --> B{Clinical signs of pneumonia?}:::decision B -->|Yes| C[CXR + blood culture]:::action C --> D{Severity assessment}:::decision D -->|Non-severe CAP| E[Ceftriaxone 50-80 mg/kg/day]:::action D -->|Severe/sepsis| F[Ceftriaxone 80 mg/kg/day + supportive care]:::action E --> G[Review culture, adjust if needed]:::action F --> H[ICU monitoring, consider additional agents]:::action ``` [cite:IAP Textbook of Pediatrics 12e, Harrison 21e Ch 297]